Skip to main content
. 2022 Jul 14;2022:8334083. doi: 10.1155/2022/8334083

Table 1.

Selected laboratory test results.

Component Initial presentation (0+) Day 5+ Five weeks after initial presentation (day 35+) One month after initiation of therapy (day 67+)
Hemoglobin (gm/dL) 12.5 13.0 11.4 10.9
WBC (K/UL) 4.2 5.1 1.5 3.7
Neutrophil percent (%) 45 60.1 67 N/A
Lymphocyte percent (%) 31 23.3 26 N/A
Eosinophil percent (%) 7 6.1 3 N/A
C-reactive protein (mg/dL) 5.1 3.9 4.45 N/A
D-dimer (ug/mL) 1.38 N/A N/A N/A
Procalcitonin (ng/mL) 0.06 0.04 0.12 N/A
Histo urine Ag (ng/mL) N/A <0.4 6.56 N/A
Histo serum Ag (ng/mL) N/A <0.4 0.49 N/A
1,3 beta D glucan (pg/mL) N/A <31 <31 N/A
AST (U/L) 35 55 60 18
ALT (U/L) 37 83 62 17
ALP (U/L) 83 164 120 72
Lactate dehydrogenase (U/L) N/A 265 N/A N/A

Diagnosis of histoplasmosis.